+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fluoxetine"

Fluoxetine Global Market Report 2024 - Product Thumbnail Image

Fluoxetine Global Market Report 2024

  • Report
  • August 2024
  • 175 Pages
  • Global
From
Antidepressants - Global Strategic Business Report - Product Thumbnail Image

Antidepressants - Global Strategic Business Report

  • Report
  • April 2025
  • 174 Pages
  • Global
From
Antidepressants Market Report 2025 - Product Thumbnail Image

Antidepressants Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Olanzapine Market Report 2025 - Product Thumbnail Image

Olanzapine Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Post-Traumatic Stress Disorder Therapeutics Market Report 2025 - Product Thumbnail Image

Post-Traumatic Stress Disorder Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026 - Product Thumbnail Image

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026

  • Report
  • February 2021
  • 420 Pages
  • United States
From
Mental Illness Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Mental Illness Drugs Industry Forecasts - China Focus

  • Report
  • March 2025
  • 92 Pages
  • China
From
From
Bipolar Depression - Pipeline Insight, 2024 - Product Thumbnail Image

Bipolar Depression - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
From
From
Mental Illness Drugs Markets in China - Product Thumbnail Image

Mental Illness Drugs Markets in China

  • Report
  • March 2025
  • 251 Pages
  • China
From
Loading Indicator

Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) used to treat mental disorders such as depression, obsessive-compulsive disorder (OCD), bulimia nervosa, and panic disorder. It is one of the most commonly prescribed drugs for mental disorders, and is available in both generic and brand-name formulations. Fluoxetine is also used to treat premenstrual dysphoric disorder (PMDD) and is sometimes used off-label to treat other conditions such as anxiety, bipolar disorder, and post-traumatic stress disorder (PTSD). The Fluoxetine market is highly competitive, with a number of major pharmaceutical companies offering their own branded versions of the drug. These companies are engaged in research and development activities to develop new formulations and delivery systems for Fluoxetine. Additionally, generic versions of the drug are widely available, providing an affordable alternative for patients. Some of the major companies in the Fluoxetine market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Mylan. Show Less Read more